| DiGeorge syndrome/velocardiofacial syndrome: the chromosome 22q11.2 deletion syndrome. | |
| | |
MedLine Citation:
|
PMID: 17712990 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Chromosome 22q11.2 deletion (CH22qD) syndrome is also known as DiGeorge syndrome or velocardiofacial syndrome. This deletion syndrome is extremely common with nearly one in 4000 children being affected. Recent advances and a holistic approach to patients have improved the care and well-being of these patients. This review will summarize advances in understanding the health needs and immune system of patients with CH22qD syndrome. Patients will most often need interventions directed at maximizing function for many organ systems but can ultimately have a high level of functioning. |
| | |
Authors:
|
Kathleen E Sullivan |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Advances in experimental medicine and biology Volume: 601 ISSN: 0065-2598 ISO Abbreviation: Adv. Exp. Med. Biol. Publication Date: 2007 |
Date Detail:
|
Created Date: 2007-08-23 Completed Date: 2007-10-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0121103 Medline TA: Adv Exp Med Biol Country: United States |
Other Details:
|
Languages: eng Pagination: 37-49 Citation Subset: IM |
Affiliation:
|
Department of Pediatrics, Division of Allergy & Immunology, Children's Hospital of Philadelphia, Philadelphia, PA, USA. sullivak@mail.med.upenn.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Allergy and Immunology Child Child, Preschool Chromosome Deletion Chromosomes, Human, Pair 22* DiGeorge Syndrome / diagnosis*, genetics*, immunology Gene Deletion* Humans Infant Infant, Newborn Models, Genetic |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked inheritance: model for autoaggressio...
Next Document: Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options.